Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Atlantic's CT-1 and CT-2 prevent restenosis

Nov. 1, 1996

CPC-111 clinical results presented at congress

Nov. 1, 1996

Na+ channel inhibitor as cardioprotectant

Nov. 1, 1996

Tyrosine kinase inhibitor for restenosis

Nov. 1, 1996

VasoCare therapy for hypertension

Nov. 1, 1996

New dual ACE/NEP inhibitors claimed by Bristol-Myers Squibb

Nov. 1, 1996

Ono discloses cGMP-PDE/TxA2 synthase inhibitors

Nov. 1, 1996

Anti-TNF MAb effective in treating septic shock in two major studies

Oct. 25, 1996

Progress on Neuprex for hemorrhagic trauma

Oct. 25, 1996

cGMP PDE inhibitors reported by DuPont Merck

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...